-ai.png)
Innovate UK is launching a Contracts for Innovation competition to accelerate the development and commercialisation of non-animal methods that improve how the sector assesses pre-clinical pharmacokinetics (PK) and cardiovascular (CV) safety.
The competition is designed to support disruptive and innovative alternatives that can either be qualified for broad adoption, or strengthened so they are more applicable in real-world drug development workflows. Your Phase 1 work should demonstrate feasibility and clearly lay the groundwork for a credible Phase 2 plan, with the longer-term expectation that successful projects will help deliver models that meet the accuracy, cost, and throughput required to replace equivalent in vivo approaches.
Key dates
Funding and project parameters
Who can apply
Lead applicants can be an organisation of any size, including those based internationally, but the majority of project work and key deliverables must be completed in the UK. Subcontractors are permitted for specialist skills, and contracts are awarded to a single legal entity. You must intend to exploit the primary outputs of the project in the UK.
Scope and themes
Projects must focus on developing new approaches or further developing existing ones that can be deployed in drug development settings. The competition targets progress towards government aims to reduce animal use in:
The call welcomes a range of technologies and maturity levels, using a portfolio approach. Themes include, but are not limited to:
Pharmacokinetic studies
Cardiovascular safety
How Inventya can help
Inventya supports organisations to compete effectively in high-demand Innovate UK calls by combining technical proposal expertise with commercial strategy and bid management discipline. For this competition, we can help you:
Hurry and contact us now to get a headstart on the application.
